IPRIPR2025-00685Final Written Decision
CSPC Megalith Biopharmaceutical Co., Ltd. et al.v.Shanghai Miracogen Inc. et al.
IPR challenge of US 10792370.
Type
IPR
Filed
Mar 3, 2025
Instituted
Oct 14, 2025
Decided
Oct 8, 2026
Patent
Application
15550995
Inventor
Chaohong Hu
Granted
Oct 6, 2020
01
Timeline
3 milestones
2025-03-03Petition filed
2025-10-14Institution
2026-10-08Terminated
02
Parties & counsel
Petitioner
CSPC Megalith Biopharmaceutical Co., Ltd. et al.
Counsel
Chen, Joeet al
Patent Owner
Shanghai Miracogen Inc. et al.
Counsel
Ponder, Christopheret al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →